Polycyclic aromatic hydrocarbons and cancer in man

Area of Science:

• Environmental Health
• Occupational Medicine
• Toxicology

Background:

• Polycyclic Aromatic Hydrocarbons (PAHs) are known human carcinogens linked to industrial processes.
• Previous classifications of PAHs as carcinogens lacked direct epidemiological evidence in occupational settings.
• Assessing PAH exposure requires reliable quantitative measurements and appropriate non-exposed comparison groups.

Purpose of the Study:

• To review recent epidemiological studies on the carcinogenic effects of PAHs in occupationally exposed individuals.
• To evaluate the dose-dependent relationship between PAH exposure and cancer risk.
• To reassess the adequacy of current occupational exposure limits for PAHs.

Main Methods:

• Systematic review of epidemiological studies investigating PAH exposure and cancer incidence.
• Quantitative analysis of PAH exposure levels and corresponding cancer risks.
• Comparison of cancer risks in exposed cohorts versus non-exposed control groups.

Main Results:

• Epidemiological studies provide direct evidence of PAH carcinogenicity in occupationally exposed subjects.
• Lung and bladder cancer risks demonstrate a clear dose-dependent relationship with PAH exposure.
• The current threshold limit value for benzene soluble matter (indicating PAH exposure) is associated with significant cancer risks.

Conclusions:

• The current threshold limit value of 0.2 mg/m3 for benzene soluble matter is insufficient to protect workers from cancer.
• Forty years of exposure at the current limit value increases lung cancer risk by 1.2-1.4 times and bladder cancer risk by 2.2 times.
• Stricter regulations and lower occupational exposure limits for PAHs are necessary to mitigate cancer risks.